i agree with this. but we remain a company with n
Post# of 144111
once we get either COVID or HIV across the goal line for an actual approval to sell the drug, the doors will open. Until then, we're in no-man's land.
i reman hopeful that Brazil is starting. great PR today, but not the one i'm looking for - i already knew we had strong initial TNBC results - yeah, this is more info, but nothing new.
If i were a skeptic, i'd say the company put this PR out given that they're unable to put the one out that really matters right now - starting the Brazil COVID trial. for me, it's the elephant in the room, because everything else is next year at least.